Erasca, Inc. (ERAS)
NASDAQ·Healthcare·Biotechnology
$14.14
-9.04%
Mkt Cap $5.22B
Analyst Ratings
Buy
4
Hold
4
Sell
0
Price Target (17 analysts)
$17.50
Range $10.00 – $30.00
Implied Upside
+23.8%
Consensus $17.50 vs current $14.14
NASDAQ·Healthcare·Biotechnology
$14.14
-9.04%
Mkt Cap $5.22B
Buy
4
Hold
4
Sell
0
Price Target (17 analysts)
$17.50
Range $10.00 – $30.00
+23.8%
Consensus $17.50 vs current $14.14